Barrios, B. E., Baez, N. S., Reynolds, D., Iribarren, P., Cejas, H., Young, H. A., & Rodriguez Galan, M. C. (2014). Abrogation of TNFα Production during Cancer Immunotherapy Is Crucial for Suppressing Side Effects Due to the Systemic Expression of IL-12. Web
Citación estilo ChicagoBarrios, Bibiana Elisabet, Natalia Soledad Baez, Della Reynolds, Pablo Iribarren, Hugo Cejas, Howard A. Young, and Maria Cecilia Rodriguez Galan. Abrogation of TNFα Production During Cancer Immunotherapy Is Crucial for Suppressing Side Effects Due to the Systemic Expression of IL-12. 2014.
Cita MLABarrios, Bibiana Elisabet, et al. Abrogation of TNFα Production During Cancer Immunotherapy Is Crucial for Suppressing Side Effects Due to the Systemic Expression of IL-12. 2014.